Thai Q Nguyen et al., 2024-11: Nguyen et al. show fenbendazole plus diisopropylamine dichloroacetate kills A549 lung cancer cells synergistically through ROS, Bcl-2 downregulation, BAX upregulation and caspase-3/7 and PARP activation.
After 48 h of treatment, the FZ-DADA combination produced reactive oxygen species (ROS) and promoted apoptosis by down-regulating Bcl2 and up-regulating BAX protein expression.
Thai Q Nguyen et al., 2024-11: Nguyen et al. show fenbendazole plus diisopropylamine dichloroacetate kills A549 lung cancer cells synergistically through ROS, Bcl-2 downregulation, BAX upregulation and caspase-3/7 and PARP activation. Study type: A549 lung cancer cell line in vitro. N: not applicable. Country: Vietnam and USA (University of Science and Technology of Hanoi; USC). Dose: not stated in the abstract text captured; 48 h treatment. Funder: not stated in the record; the group's companion in vivo paper declares funding by Thai Minh Pharmaceuticals JSC. Declared conflicts: no COI statement in the record. Comparator: fenbendazole alone, DADA alone, and untreated cells. Cell-culture only: the in vivo counterpart of this combination is the mouse xenograft recorded separately under the animal claim. Study type: lab.
